SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001552781-17-000019
Filing Date
2017-01-13
Accepted
2017-01-13 09:00:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 e17015_sln-sc13d.htm SC 13D 50754
  Complete submission text file 0001552781-17-000019.txt   52504
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-48710 | Film No.: 17526584
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filed by) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D